Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator

被引:53
作者
Kashanchi, F
Agbottah, ET
Pise-Masison, CA
Mahieux, R
Duvall, J
Kumar, A
Brady, JN
机构
[1] NIH, NCI, Virus Tumor Biol Sect, LRGBE, Bethesda, MD 20892 USA
[2] George Washington Univ, Dept Biochem, Washington, DC USA
关键词
D O I
10.1128/JVI.74.2.652-660.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cyclin-dependent kinases are required for the Tat-dependent transition from abortive to productive elongation. Further, the human immunodeficiency virus type 1 (HIV-1) Vpr protein prevents proliferation of infected cells by arresting them in the G(2) phase of the cell cycle. These findings suggest that the life cycle of the virus may be integrally related to the cell cycle. We now demonstrate by in vitro transcription analysis that Tat-dependent transcription takes place in a cell cycle-dependent manner. Remarkably, Tat activates gene expression in two distinct stages of the cell cycle. Tat-dependent long terminal repeat activation is observed in G(1). This activation is TAR dependent and requires a functional Sp1 binding site. A second phase of transactivation by Tat is observed in G(2) and is TAR independent. This later phase of transcription is enhanced by a natural cell cycle blocker of HIV-1, vpr, which arrests infected cells at the G(2)/M boundary. These studies link the HIV-1 Tat protein to cell cycle-specific biological functions.
引用
收藏
页码:652 / 660
页数:9
相关论文
共 92 条
[1]   DNA-DAMAGE IN HUMAN B-CELLS CAN INDUCE APOPTOSIS, PROCEEDING FROM G(1)/S WHEN P53 IS TRANSACTIVATION COMPETENT AND G(2)/M WHEN IT IS TRANSACTIVATION DEFECTIVE [J].
ALLDAY, MJ ;
INMAN, GJ ;
CRAWFORD, DH ;
FARRELL, PJ .
EMBO JOURNAL, 1995, 14 (20) :4994-5005
[2]   Yeast TAF(II)90 is required for cell-cycle progression through G(2)/M but not for general transcription activation [J].
Apone, LM ;
Virbasius, CMA ;
Reese, JC ;
Green, MR .
GENES & DEVELOPMENT, 1996, 10 (18) :2368-2380
[3]   ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES [J].
BALOTTA, C ;
LUSSO, P ;
CROWLEY, R ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4409-4414
[4]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[5]   DETAILED MUTATIONAL ANALYSIS OF TAR RNA - CRITICAL SPACING BETWEEN THE BULGE AND LOOP RECOGNITION DOMAINS [J].
BERKHOUT, B ;
JEANG, KT .
NUCLEIC ACIDS RESEARCH, 1991, 19 (22) :6169-6176
[6]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[7]   Canventol inhibits HIV-1 replication by a Tat-induced Tar-independent mechanism [J].
Biswas, DK ;
Tius, MA ;
Zhuo, JC ;
Pardee, AB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 12 (02) :120-127
[8]  
Bohan Cindy A., 1992, Gene Expression, V2, P391
[9]   Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys [J].
Brother, MB ;
Chang, HK ;
Lisziewicz, J ;
Su, D ;
Murty, LC ;
Ensoli, B .
VIROLOGY, 1996, 222 (01) :252-256
[10]   EFFECTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN ON THE EXPRESSION OF INFLAMMATORY CYTOKINES [J].
BUONAGURO, L ;
BARILLARI, G ;
CHANG, HK ;
BOHAN, CA ;
KAO, V ;
MORGAN, R ;
GALLO, RC ;
ENSOLI, B .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7159-7167